Safety of therapies using ustekinumab in patients with psoriasis who have had hepatitis B virus infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of therapies using ustekinumab in patients with psoriasis who have had hepatitis B virus infection

Published:2021-12-28 Issue: Volume: Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Kłujszo Elżbieta Halina¹,Zarębska‐Michaluk Dorota²,Kręcisz Beata³,Witkowska Anna⁴

Affiliation:

1. Clinic of Dermatology Wojewódzki Szpital Zespolony Kielce Poland

2. Department of Infectious Diseases Jan Kochanowski University in Kielce Kielce Poland

3. Faculty of Medicine and Health Science Jan Kochanowski University in Kielce Kielce Poland

4. Department of Rheumatology Mater Misericordiae University Hospital Dublin Ireland

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15274

Reference53 articles.

1. Clinical and Basic Immunodermatology

2. Comparison of Biologics and Oral Treatments for Plaque Psoriasis

3. New therapies versus first-generation biologic drugs in psoriasis: a review of adverse events and their management

4. Hepatitis B Virus Infection

5. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors;Rheumatology;2024-08-17

2. Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn’s Disease on Ustekinumab: A Nationwide Real-World Study;Inflammatory Bowel Diseases;2023-03-06

3. Meta‐analysis: hepatitis B reactivation in patients receiving biological therapy;Alimentary Pharmacology & Therapeutics;2022-08-17

4. Hepatitis B Virus Reactivation and Mycobacterial Infections Associated With Ustekinumab: A Retrospective Study of an International Pharmacovigilance Database;Frontiers in Pharmacology;2022-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3